Suppression of recurrent transient ischemic attacks by a statin agent

Neurology

Volumn 56, Issue 4, 2001, Pages 531-532

  Alberts, M J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; WARFARIN;

ADULT; AGED; ARTICLE; CASE REPORT; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG MECHANISM; DYSPHAGIA; FEMALE; HUMAN; MALE; PARESTHESIA; PRIORITY JOURNAL; SLURRED SPEECH; STROKE; TRANSIENT ISCHEMIC ATTACK; VERTIGO;

EID: 0035957086     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.4.531     Document Type: Article

References (10)

1. HMG-CoA reductase inhibitor therapy and stroke risk reduction: An analysis of clinical trials data
2. Effects of lovastatin and warfarin on early carotid atherosclerosis: Sex-specific analyses
3. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
4. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
5. Pravastatin therapy and the risk of stroke
6. Reduction of stroke incidence after myocardial infarction with pravastatin: The Cholesterol and Recurrent Events (CARE) study
7. Antiatherothrombotic properties of statins. Implications for cardiovascular event reduction
8. Effects of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia
9. Hypercoagulable state in patients with hypercholesterolemia: Effects of pravastatin
10. Vascular effects of statins in stroke